No ASX ETF holds Mayne Pharma (MYX) as of 15 Oct 2026. Over the last 3 months it fell 11.7%: on $10,000, −$1170. We explain 2 big moves in that time.
About MYX
- SectorHealth Care
- IndustryPharmaceuticals, Biotechnology & Life Sciences
- Size$208.0m
- Held by0 ETFs
- Big moves2 in 3M
Last 3 months−11.7%
$2.49−11.70% price
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
3M high$3.30
3M low$2.49
Avg volume218k
Latest volume159k
Prices to 15 Oct closeNo distributions in this period
Why it moved
2 moves
- −5.7%10 Sep 2026· No Catalyst Found
MYX fell alongside a broad healthcare sector sell-off, with the ASX health index down 2.3% and 36 industry peers down a median 2.3% on the same day.
- +10.2%peak +11.3%3 Aug 2026· Sector Flow
MYX.AX rose sharply alongside a broad rally in the ASX healthcare sector, which gained over 2.3% on the same day, lifting sentiment across health-related stocks.
Held by 0 ETFs
No ETF we track holds MYX directly.
Other Health Care companies
- SHLSonic Healthcare47 ETFs
- RMDResMed44 ETFs
- CSLCSL Limited42 ETFs
- BDXBcal36 ETFs
- CSXCleanspace36 ETFs
- REGRegis Health33 ETFs
- TLXTelix Pharma32 ETFs
- SIGSigma Healthcare31 ETFs